JIANG Yingyu, GU Hongqiu. Sample Size Estimation for the Development and Validation of Clinical Prediction Models[J]. Chinese Journal of Stroke, 2024, 19(5): 489-495.
[1]PEDUZ P，CONCATO J，KEMPER E，et al. A simulation study of the number of events per variable in logistic regression analysis[J]. J Clin Epidemiol，1996，49（12）：1373-1379.
[2] PEDUZZI P，CONCATO J，FEINSTEIN A R，et al. Importance of events per independent variable in proportional hazards regression analysis Ⅱ. Accuracy and precision of regression estimates[J]. J Clin Epidemiol，1995，48（12）：1503-1510.
[3] OGUNDIMU E O，ALTMAN D G，COLLINS G S. Adequate sample size for developing prediction models is not simply related to events per variable[J/OL]. J Clin Epidemiol，2016，76：175-182[2024-04-10]. https://doi.org/10.1016/j.jclinepi.2016.02.031.
[4] VITTINGHOFF E，MCCULLOCH C E. Relaxing the rule of ten events per variable in logistic and Cox regression[J]. Am J Epidemiol，2007，165（6）：710-718.
[5] AUSTIN P C，STEYERBERG E W. Events per variable（EPV）and the relative performance of different strategies for estimating the out-of-sample validity of logistic regression models[J]. Stat Methods Med Res，2017，26（2）：796-808.
[6] RILEY R D，ENSOR J，SNELL K I E，et al. Calculating the sample size required for developing a clinical prediction model[J/OL]. BMJ，2020，368：m441[2024-04-10]. https://doi.org/10.1136/bmj.m441.
[7] PATE A，RILEY R D，COLLINS G S，et al. Minimum sample size for developing a multivariable prediction model using multinomial logistic regression[J]. Stat Methods Med Res，2023，32（3）：555-571.
[8] CHRISTODOULOU E，VAN SMEDEN M，EDLINGER M，et al. Adaptive sample size determination for the development of clinical prediction models[J/OL]. Diagn Progn Res，2021，5（1）：6[2024-04-10]. https://doi.org/10.1186/s41512-021-00096-5.
[9] COLLINS G S，OGUNDIMU E O，ALTMAN D G. Sample size considerations for the external validation of a multivariable prognostic model：a resampling study[J]. Stat Med，2016，35（2）：214-226.
[10] VAN CALSTER B，NIEBOER D，VERGOUWE Y，et al. A calibration hierarchy for risk models was defined：from utopia to empirical data[J/OL]. J Clin Epidemiol，2016，74：167-176[2024-04-10]. https://doi.org/10.1016/j.jclinepi.2015.12.005.
[11] ARCHER L，SNELL K I E，ENSOR J，et al. Minimum sample size for external validation of a clinical prediction model with a continuous outcome[J]. Stat Med，2021，40（1）：133-146.
[12] RILEY R D，SNELL K I E，ARCHER L，et al. Evaluation of clinical prediction models（part 3）：calculating the sample size required for an external validation study[J/OL]. BMJ，2024，384：e074821[2024-04-10]. https://doi.org/10.1136/bmj-2023-074821.
[13] RILEY R D，DEBRAY T P A，COLLINS G S，et al. Minimum sample size for external validation of a clinical prediction model with a binary outcome[J]. Stat Med，2021，40（19）：4230-4251.
[14] RILEY R D，COLLINS G S，ENSOR J，et al. Minimum sample size calculations for external validation of a clinical prediction model with a time-to-event outcome[J]. Stat Med，2022，41（7）：1280-1295.
[15]XU R H，WEI W，KRAWCZYK M，et al. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma[J]. Nat Mater，2017，16（11）：1155-1161.
